This work demonstrates these limitations and proposes iodo silanes as a superior alternative to amino silanes via a case study involving the synthesis of MIP nanoparticles against epitopes of epidermal growth factor receptor (EGFR), a cancer biomarker of great clinical significance. This evidence concerns the gene EGFR and cancer.